One Dog, One Stubborn Problem, and a Surprising Drug
Calcium oxalate stones in dogs are painful, persistent, and notoriously hard to prevent from coming back. A case report published in BMC Veterinary Research documents something unusual: the off-label use of dapagliflozin — a drug normally prescribed to people with type 2 diabetes — in a single dog whose urinary stones kept recurring. The drug did not reduce the dog’s urinary calcium levels and was stopped early due to safety concerns. This is one dog’s story, not a clinical trial, and its outcome raises important cautions rather than new treatment options.
Important note right away: This was a highly specialized decision made under close veterinary supervision. It is not something any pet owner should attempt without professional guidance.
Why Calcium Oxalate Stones Are So Difficult to Manage
If your dog has ever been diagnosed with bladder or kidney stones, there is a reasonable chance they were calcium oxalate stones. These are small, hard mineral deposits — imagine salt crystals forming inside a pipe — that build up in a dog’s urinary system. Unlike sand or fine grit, these crystals are sharp and can cause real pain and blockages.
One of the biggest challenges with calcium oxalate stones is that they are difficult to dissolve with diet or medication alone. Depending on their size and location, stones may require surgical removal. And for some dogs, they keep forming even after successful removal. Dietary changes and increased water intake can reduce the risk, but they do not work for every dog.
Here is why recurrent cases are especially hard to treat:
- There are very few medications approved specifically for this type of stone in dogs
- Some dogs have an underlying body chemistry issue that keeps producing stones
- Surgery can remove existing stones but cannot stop new ones from forming
- Managing the root cause — why the stones form in the first place — is the real challenge
For these tough cases, veterinary researchers are always on the lookout for new approaches.
What Is Dapagliflozin, and Why Was It Considered?
Dapagliflozin (da-pa-GLEE-flo-zin) is a medication used to treat type 2 diabetes in people. It belongs to a group of drugs called SGLT2 inhibitors. Think of SGLT2 inhibitors as a kind of “kidney filter override” — they tell the kidneys to pass extra glucose (blood sugar) out through urine instead of keeping it in the bloodstream.
You might wonder: what does a diabetes drug have to do with kidney stones?
Here is the connection. SGLT2 inhibitors change how the kidneys handle several substances — not just sugar. Some of those changes affect how calcium and other minerals are filtered. In human medicine, researchers have been exploring whether these drugs might reduce the risk of kidney stone formation in people with diabetes. That line of thinking prompted veterinary specialists to ask the same question for dogs.
Using a human drug in a dog for a purpose it was not originally approved for is called “off-label” use. This happens regularly in veterinary medicine. When no approved veterinary option exists and the scientific reasoning is sound, vets sometimes try medications from human medicine under close monitoring.
What This Case Report Found
This study is a case report — a detailed account of what happened with one specific dog. It is one of the earliest forms of medical evidence. Think of it as a “here is something we tried and here is what we observed” report, not a “here is proof this works” study.
Key details from the report:
- The patient: One dog with a history of recurrent calcium oxalate urolithiasis (the medical term for stones in the urinary tract)
- The treatment: Dapagliflozin was used off-label as part of the dog’s medical management
- The outcome: Urinary calcium-to-creatinine ratio remained elevated throughout the trial period. The dog developed glucosuria (sugar in the urine), acidic urine, and increased urine specific gravity — signs that the drug was affecting kidney filtration but not reducing calcium excretion
- Duration: Dapagliflozin was discontinued after 12 days due to concerns about underhydration
- The authors’ conclusion: Short-term treatment did not reduce hypercalciuria (excess calcium in the urine). The authors noted it may actually increase lithogenic risk — the tendency to form stones — if fluid intake does not keep pace with the osmotic diuresis (increased urine production) the drug causes
This report does not demonstrate that dapagliflozin is effective or safe for dogs with calcium oxalate stones. It documents that the drug was tried, describes what was observed, and highlights that the therapeutic role and safety profile remain unknown.
What This Means for Dog Owners
What This Case Does and Does Not Tell Us
This case report documents one attempt to use dapagliflozin in a dog with recurrent calcium oxalate stones. The drug did not reduce the dog’s urinary calcium levels during the trial, and it was stopped after less than two weeks because of safety concerns. The authors do not conclude that dapagliflozin is an effective or safe option for this condition — quite the opposite. They raise the possibility that the drug could make stone formation worse in dogs who do not drink enough water to compensate.
This case does not open a new treatment path for calcium oxalate stones. It documents a single exploratory attempt with an unfavorable outcome and identifies questions that would need to be answered before the drug could be considered further in this context.
Never Try This at Home
Dapagliflozin carries real risks, and those risks are even less understood in dogs than in people. SGLT2 inhibitors can affect kidney function, electrolyte balance (the balance of key minerals like sodium and potassium in the blood), blood sugar levels, and the urinary tract. In humans, this drug is used with regular blood tests and careful monitoring. In dogs, the appropriate dosing, safety profile, and long-term effects are not yet well established.
Giving your dog a human prescription medication — especially one that affects the kidneys — without veterinary oversight could be seriously harmful. If your dog has recurrent stones, work with a veterinarian or a veterinary internal medicine specialist, not a pharmacy shelf.
When to Seek Veterinary Help
Contact your veterinarian if your dog shows any of these signs:
- Straining to urinate or going to the bathroom much more often than usual
- Blood in the urine
- Crying out or seeming uncomfortable in the belly area
- A previous stone diagnosis and ongoing recurrences despite treatment
Ask about a referral to a veterinary internal medicine specialist if your dog’s stones keep coming back. Specialists have access to the latest research and can consider more advanced management options with proper monitoring.
Study Limitations: One Dog Is Not the Full Picture
The most important thing to know about this study is that it involves just one dog. A single case report cannot tell us whether a drug is safe, whether it works for most dogs, or what the right dose should be. It can only tell us what happened in one specific situation under specialist care.
In this case, the outcome was unfavorable: the treatment target was not achieved, adverse changes in urine chemistry appeared, and the drug was stopped before completing even two weeks of use. Larger, controlled studies with appropriate safety monitoring would be needed before this drug could be evaluated meaningfully for this purpose — and this report, with its unfavorable findings, does not provide a basis for pursuing that path.
The Bottom Line
Calcium oxalate stones in dogs are a real challenge, especially when they keep coming back after treatment. This case report documents an attempt to use a human diabetes drug off-label in one dog — and that attempt did not produce positive results. The dog’s urinary calcium levels stayed high, adverse urinary changes developed, and the drug was stopped early. The authors concluded that this approach did not reduce hypercalciuria and may carry added risk in dogs with inadequate fluid intake.
If your dog has recurrent urinary stones, the best path forward is a conversation with your veterinarian or a specialist. Management of calcium oxalate stones is highly individual and guided by your dog’s specific test results. Dietary management, appropriate hydration, and close monitoring remain the foundation of care. Any treatment decision belongs with a professional who can evaluate your pet’s full clinical picture.
This article summarizes peer-reviewed research for educational purposes. Always consult with your veterinarian for personalized advice about your pet’s health and behavior.